ScreenPoint Medical Showcases Transpara® AI Breast Care Software Designed to Improve Cancer Detection and Workflow at RSNA

Studies Being Presented at RSNA Shows that the Use of Transpara May Safely Reduce Workload and Maintain Accurate Cancer Detection in Mammography

ScreenPoint Medical is showcasing Transpara®, the world’s leading artificial intelligence (AI) breast care software, here at the 108^th Annual Radiological Society of North America (RSNA) meeting, November 27-December 1, 2022 (South Hall #4141). The performance of Transpara is the subject of research being presented this week at RSNA, with two studies demonstrating the potential for Transpara to safely reduce workload in the clinical workflow of a double-reading breast cancer screening program.

Read the full release here